Celldex Therapeutics
CLDX
#4701
Rank
$1.95 B
Marketcap
$29.45
Share price
-0.51%
Change (1 day)
13.01%
Change (1 year)

Celldex Therapeutics (CLDX) - Cash on Hand

Cash on Hand as of September 2025 : $0.58 Billion USD

According to Celldex Therapeutics's latest financial reports the company has $0.58 Billion USD in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Celldex Therapeutics - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31$0.72 B71.22%
2023-12-31$0.42 B38.91%
2022-12-31$0.30 B-25.3%
2021-12-31$0.40 B109.98%
2020-12-31$0.19 B201.98%
2019-12-31$64.38 M-31.52%
2018-12-31$94.02 M-32.57%
2017-12-31$0.13 B-26.53%
2016-12-31$0.18 B-34.53%
2015-12-31$0.28 B44.19%
2014-12-31$0.20 B-33.65%
2013-12-31$0.30 B260.86%
2012-12-31$83.96 M57.49%
2011-12-31$53.31 M-12.74%
2010-12-31$61.09 M-25.9%
2009-12-31$82.45 M86.3%
2008-12-31$44.25 M801.45%
2007-12-31$4.9 M-88%
2006-12-31$40.91 M74.69%
2005-12-31$23.41 M-26.22%
2004-12-31$31.74 M56.74%
2003-12-31$20.25 M-19.22%
2002-12-31$25.07 M-41.24%
2001-12-31$42.66 M-14.97%
2000-12-31$50.17 M268.43%
1999-12-31$13.61 M53.02%
1998-12-31$8.9 M39.06%
1997-12-31$6.4 M-49.21%
1996-12-31$12.6 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Seagen
SGEN
$1.23 B 112.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
$3.45 M-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
$0.24 B-57.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
$9.44 B 1,519.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
$14.98 B 2,469.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
$4.44 B 662.04%๐Ÿ‡ฌ๐Ÿ‡ง UK
Titan Pharmaceuticals
TTNP
$2.8 M-99.52%๐Ÿ‡บ๐Ÿ‡ธ USA